Overview

Full Product Details

Author:   Carlo Masserdotti (IDEXX Laboratories, Brescia, Italy)
Publisher:   John Wiley and Sons Ltd
Imprint:   Wiley-Blackwell
Dimensions:   Width: 15.80cm , Height: 1.80cm , Length: 23.10cm
Weight:   0.590kg
ISBN:  

9781119895541

ISBN 10:   1119895545
Pages:   288
Publication Date:   16 September 2023
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Available To Order  
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

About the Author ix Foreword xi Preface xiii Acknowledgments xv 1 Before the Analysis: Rules for Interpretation of Hepatic Cytology 1 1.1 The Rules for Cytological Diagnosis of Hepatic Diseases 2 1.1.1 Rule 1 2 1.1.2 Rule 2 2 1.1.3 Rule 3 2 1.1.4 Rule 4 3 1.1.5 Rule 5 3 1.1.6 Rule 6 3 1.1.7 Rule 7 4 1.1.8 Rule 8 4 1.2 Diagnostic Approach to Liver Disease 4 1.2.1 Clinical and Anamnestic Signs 5 1.2.2 Hematochemical Investigation 5 1.2.2.1 Pathological Bases of Liver Damage 5 1.2.2.2 Diagnosis of Liver Damage 8 1.2.2.3 Useful Enzymes for Recognition of Damage to Hepatocytes and Cholangiocytes 9 1.2.2.4 Liver Failure Diagnosis 11 1.2.2.5 Parameters of Liver Failure 12 1.2.3 Ultrasonographic Investigation 14 1.2.4 Cytological and Histopathological Investigation 15 1.2.4.1 Sample Collection 15 1.2.4.2 Cytological Approach to Hepatic Diseases 16 1.3 Key Points 16 References 17 2 Normal Histology and Cytology of the Liver 19 2.1 Normal Histology of the Liver 19 2.2 Normal Cytology of the Liver 27 2.2.1 Hepatocytes 28 2.2.2 Kupffer Cells 30 2.2.3 Stellate Cells (Ito Cells) 31 2.2.4 Cholangiocytes (Biliary Cells) 32 2.2.5 Hepatic Lymphocytes 33 2.2.6 Hepatic Mast Cells 34 2.2.7 Hematopoietic Cells 34 2.2.8 Mesothelial Cells 36 2.3 Key Points 38 References 39 3 Nonspecific and Reversible Hepatocellular Damage 41 3.1 Accumulation of Water 42 3.2 Accumulation of Glycogen 43 3.3 Accumulation of Lipids 46 3.4 Accumulation of Bilirubin and Bile Salts 57 3.5 Hyperplasia of Stellate Cells 57 3.6 Regenerative Changes 59 3.7 Key Points 64 References 64 4 Intracytoplasmic and Extracytoplasmic Pathological Accumulation 67 4.1 Pathological Intracytoplasmic Accumulation 67 4.1.1 Lipofuscin 67 4.1.2 Copper 73 4.1.3 Iron and Hemosiderin 76 4.1.4 Protein Droplets 82 4.1.5 Cytoplasmic Granular Eosinophilic Material 82 4.1.6 Hepatic Lysosomal Storage Disorders 85 4.2 Pathological Extracytoplasmic Accumulation 86 4.2.1 Bile 86 4.2.2 Amyloid 90 4.3 Key Points 96 References 96 5 Irreversible Hepatocellular Damage 101 5.1 Necrosis 101 5.2 Apoptosis 107 5.3 Key Points 110 References 110 6 Inflammation 113 6.1 Presence of Neutrophilic Granulocytes 115 6.2 Presence of Eosinophilic Granulocytes 123 6.3 Presence of Lymphocytes and Plasma Cells 125 6.4 Presence of Macrophages 130 6.5 Presence of Mast Cells 137 6.6 Key Points 139 References 139 7 Nuclear Inclusions 143 7.1 “Brick” Inclusions 143 7.2 Glycogen Pseudo-inclusions 144 7.3 Lead Inclusions 146 7.4 Viral Inclusions 146 7.5 Key Points 147 References 147 8 Cytological Features of Liver Fibrosis 149 8.1 Cytological Features of Liver Fibrosis 150 8.2 Key Points 159 References 160 9 Cytological Features of Biliary Diseases 163 9.1 General Features of Biliary Diseases 165 9.2 Cytological Features of Specific Biliary Diseases 167 9.2.1 Acute and Chronic Cholestasis 167 9.2.2 Acute Cholangitis 170 9.2.3 Chronic Cholangitis 170 9.2.4 Lymphocytic Cholangitis 170 9.3 Key Points 175 References 175 10 Bile and Gallbladder Diseases 177 10.1 Bactibilia and Septic Cholecystitis 179 10.2 Epithelial Hyperplasia 181 10.3 Gallbladder Mucocele 181 10.4 Limy Bile Syndrome 183 10.5 Biliary Sludge 183 10.6 Neoplastic Diseases of Gallbladder 183 10.7 Other Gallbladder Diseases 184 10.8 Key Points 184 References 184 11 Etiological Agents 187 11.1 Viruses 188 11.2 Bacteria 189 11.3 Protozoa 193 11.4 Fungi 194 11.5 Parasites 194 11.6 Key Points 197 References 197 12 Neoplastic Lesions of the Hepatic Parenchyma 199 12.1 Epithelial Neoplasia 200 12.1.1 Nodular Hyperplasia 200 12.1.2 Hepatocellular Adenoma 204 12.1.3 Hepatocellular Carcinoma 206 12.1.4 Cholangioma 215 12.1.5 Cholangiocellular Carcinoma 217 12.1.6 Other Nodular Lesions of Biliary Origin 222 12.1.7 Hepatic Carcinoid 223 12.1.8 Hepatoblastoma 227 12.2 Mesenchymal Neoplasia 227 12.2.1 Malignant Mesenchymal Neoplasms 227 12.3 Hematopoietic Neoplasia 229 12.3.1 Myelolipoma 231 12.3.2 Large Cell Hepatic Lymphoma 232 12.3.3 Small Cell Lymphoma 234 12.3.4 Large Granular Lymphocyte (LGL) Lymphoma 236 12.3.5 Epitheliotropic Lymphoma 239 12.3.6 Other Types of Hepatic Lymphoma 240 12.3.7 Malignant Histiocytic Neoplasms 242 12.3.8 Mast Cell Tumor 245 12.3.9 Hepatic Splenosis 247 12.4 Metastatic Neoplasia 247 12.5 Criteria for Selection of Sampling Methods for Liver Nodular Lesions 248 12.6 Key Points 250 References 250 Index 255 

Reviews

Author Information

Carlo Masserdotti, DVM, Dipl ECVCP, Spec Bioch Clin IAT, Consultant, Anatomic and Clinical Pathology, IDEXX Laboratories, Brescia, Italy.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions